ScoreWhy is Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 43.04%
- The company has been able to generate a Return on Capital Employed (avg) of 43.04% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of 4.90% and Operating profit at -0.61% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 21.78% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 4.90% and Operating profit at -0.61% over the last 5 years
4
The company has declared Negative results for the last 5 consecutive quarters
- NET PROFIT(HY) At CNY 1,098.51 MM has Grown at -24.18%
- ROCE(HY) Lowest at 12.38%
- INVENTORY TURNOVER RATIO(HY) Lowest at 0.92 times
5
With ROE of 12.34%, it has a very expensive valuation with a 4.28 Price to Book Value
- Over the past year, while the stock has generated a return of -39.26%, its profits have fallen by -37.7%
- At the current price, the company has a high dividend yield of 3
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.
-38.92%
-1.56
29.87%
China Shanghai Composite
3.23%
0.23
14.72%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
4.90%
EBIT Growth (5y)
-0.61%
EBIT to Interest (avg)
82.01
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.03
Sales to Capital Employed (avg)
0.66
Tax Ratio
18.26%
Dividend Payout Ratio
83.01%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
33.95%
ROE (avg)
21.78%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
35
Industry P/E
Price to Book Value
4.28
EV to EBIT
34.40
EV to EBITDA
32.70
EV to Capital Employed
4.49
EV to Sales
7.47
PEG Ratio
NA
Dividend Yield
2.98%
ROCE (Latest)
13.06%
ROE (Latest)
12.34%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 1,352.78 MM
RAW MATERIAL COST(Y)
Fallen by -7.58% (YoY
-21What is not working for the Company
NET PROFIT(HY)
At CNY 1,098.51 MM has Grown at -24.18%
ROCE(HY)
Lowest at 12.38%
INVENTORY TURNOVER RATIO(HY)
Lowest at 0.92 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 6.22 times
NET SALES(Q)
At CNY 1,831.56 MM has Fallen at -14.82%
CASH AND EQV(HY)
Lowest at CNY 5,600.63 MM
Here's what is working for Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.
Operating Cash Flow
Highest at CNY 1,352.78 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Raw Material Cost
Fallen by -7.58% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.
Net Sales
At CNY 1,831.56 MM has Fallen at -14.82%
over average net sales of the previous four periods of CNY 2,150.29 MMMOJO Watch
Near term sales trend is very negative
Net Sales (CNY MM)
Net Profit
At CNY 1,098.51 MM has Grown at -24.18%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
Inventory Turnover Ratio
Lowest at 0.92 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 6.22 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Cash and Eqv
Lowest at CNY 5,600.63 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Footer loading
